Skip to main content

GLP-1 RA Use Linked to Lower Quality of Bowel Preparation

Medically reviewed by Carmen Pope, BPharm. Last updated on June 13, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, June 13, 2024 -- The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for diabetes or obesity is associated with a lower quality of bowel preparation among patients undergoing colonoscopy, according to a study published online in the June issue of the American Journal of Gastroenterology.

Rebecca Yao, M.D., M.P.H., from the Mayo Clinic in Rochester, Minnesota, and colleagues conducted a retrospective cohort study of patients who underwent screening or surveillance colonoscopy at a large academic medical center to examine whether use of GLP-1 RA is associated with decreased quality of bowel preparation. Patients taking GLP-1 RAs for diabetes or obesity during colonoscopy were defined as cases, and those who were prescribed GLP-1 RAs at one point but not within three months of colonoscopy were included as controls (265 and 181, respectively).

The researchers found that when controlling for diabetes, the mean Boston Bowel Preparation Score (BBPS) was significantly higher in controls than cases (7.0 ± 1.9 versus 7.5 ± 2.4). The case group had a significantly higher percentage of patients with a total BBPS score of <5 (15.5 versus 6.6 percent). The case group also had a significantly higher proportion of patients who required a repeat colonoscopy due to poor bowel preparation (18.9 versus 11.1 percent).

"It will be essential to understand the cumulative effect of medications that may delay gastric emptying on the quality of bowel preparation to better understand the appropriate measures and counseling that need to be taken before undergoing outpatient colonoscopies," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted June 2024

Read this next

Casual Blood Glucose Testing Misses ~70 Percent of Gestational Diabetes Cases

FRIDAY, Sept. 27, 2024 -- Casual blood glucose (CBG) testing at 24 to 28 gestational weeks misses about 70 percent of women with gestational diabetes mellitus (GDM), according to...

Large Difference in Survival Seen for Preemies Born at 25 Versus 22 Weeks

FRIDAY, Sept. 27, 2024 -- For infants born prematurely, survival increases considerably for those born at 25 versus 22 gestational weeks, according to a study published online...

Adverse Brain Health Outcomes Increased for Sexual, Gender Minority Groups

FRIDAY, Sept. 27, 2024 -- Sexual and gender-minority (SGM) persons have increased odds of adverse brain health outcomes, according to a study published online Sept. 25 in...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.